Research and Markets (http://www.researchandmarkets.com/research/k9q6ff/hepatitis_b) has announced the addition of the "Hepatitis B - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Hepatitis B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis B and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Hepatitis B Overview
- Therapeutics Development
- Pipeline Products for Hepatitis B - Overview
- Pipeline Products for Hepatitis B - Comparative Analysis
- Hepatitis B - Therapeutics under Development by Companies
- Hepatitis B - Therapeutics under Investigation by Universities/Institutes
- Hepatitis B - Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Hepatitis B - Products under Development by Companies
- Hepatitis B - Products under Investigation by Universities/Institutes
- Hepatitis B - Companies Involved in Therapeutics Development- 35 of the 80+ Companies Featured
- Abivax S.A.
- AiCuris GmbH & Co. KG
- AIMM Therapeutics B.V.
- Akshaya Bio Inc.
- Alnylam Pharmaceuticals, Inc.
- AlphaMab Co., Ltd
- Altimmune, Inc.
- AltraVax Inc.
- Amarna Therapeutics B.V.
- Arbutus Biopharma Corporation
- Arrowhead Research Corporation
- Assembly Biosciences, Inc.
- Beijing Minhai Biotechnology Co., Ltd
- Benitec Biopharma Limited
- BioDiem Ltd
- Biogenomics Limited
- Biological E. Limited
- BioStar Pharmaceuticals, Inc.
- Bolder Biotechnology, Inc.
- Bukwang Pharm.Co., Ltd.
- CaroGen Corporation
- CEL-SCI Corporation
- Celltrion, Inc.
- Chimerix, Inc.
- Chongqing Zhifei Biological Products Co., Ltd.
- ChronTech Pharma AB
- Cocrystal Pharma, Inc.
- Cytos Biotechnology AG
- CyTuVax B.V.
- Dong-A ST Co., Ltd.
- Dynavax Technologies Corporation
- Ensemble Therapeutics Corporation
- Enyo Pharma S.A.S.
- F. Hoffmann-La Roche Ltd.
- GeneCure LLC
For more information visit http://www.researchandmarkets.com/research/k9q6ff/hepatitis_b
View source version on businesswire.com: http://www.businesswire.com/news/home/20160118005606/en/
